Clayton A - Search Results

1

Analysis of antigen presenting cell derived exosomes, based on immuno-magnetic isolation and flow cytometry.

Clayton A, Court J, Navabi H, Adams M, Mason MD, Hobot JA, Newman GR, Jasani B. Clayton A, et al. J Immunol Methods. 2001 Jan 1;247(1-2):163-74. doi: 10.1016/s0022-1759(00)00321-5. J Immunol Methods. 2001. PMID: 11150547

2

Increased exosome production from tumour cell cultures using the Integra CELLine Culture System.

Mitchell JP, Court J, Mason MD, Tabi Z, Clayton A. Mitchell JP, et al. Among authors: clayton a. J Immunol Methods. 2008 Jun 1;335(1-2):98-105. doi: 10.1016/j.jim.2008.03.001. Epub 2008 Apr 3. J Immunol Methods. 2008. PMID: 18423480

3

Antigen-presenting cell exosomes are protected from complement-mediated lysis by expression of CD55 and CD59.

Clayton A, Harris CL, Court J, Mason MD, Morgan BP. Clayton A, et al. Eur J Immunol. 2003 Feb;33(2):522-31. doi: 10.1002/immu.200310028. Eur J Immunol. 2003. PMID: 12645951 Free article.

4

Adhesion and signaling by B cell-derived exosomes: the role of integrins.

Clayton A, Turkes A, Dewitt S, Steadman R, Mason MD, Hallett MB. Clayton A, et al. FASEB J. 2004 Jun;18(9):977-9. doi: 10.1096/fj.03-1094fje. Epub 2004 Apr 1. FASEB J. 2004. PMID: 15059973

5

Induction of heat shock proteins in B-cell exosomes.

Clayton A, Turkes A, Navabi H, Mason MD, Tabi Z. Clayton A, et al. J Cell Sci. 2005 Aug 15;118(Pt 16):3631-8. doi: 10.1242/jcs.02494. Epub 2005 Jul 26. J Cell Sci. 2005. PMID: 16046478

6

Recovery of CD8+ T-cell function during systemic chemotherapy in advanced ovarian cancer.

Coleman S, Clayton A, Mason MD, Jasani B, Adams M, Tabi Z. Coleman S, et al. Among authors: clayton a. Cancer Res. 2005 Aug 1;65(15):7000-6. doi: 10.1158/0008-5472.CAN-04-3792. Cancer Res. 2005. PMID: 16061686

7

Human tumor-derived exosomes selectively impair lymphocyte responses to interleukin-2.

Clayton A, Mitchell JP, Court J, Mason MD, Tabi Z. Clayton A, et al. Cancer Res. 2007 Aug 1;67(15):7458-66. doi: 10.1158/0008-5472.CAN-06-3456. Cancer Res. 2007. PMID: 17671216

8

Human tumor-derived exosomes down-modulate NKG2D expression.

Clayton A, Mitchell JP, Court J, Linnane S, Mason MD, Tabi Z. Clayton A, et al. J Immunol. 2008 Jun 1;180(11):7249-58. doi: 10.4049/jimmunol.180.11.7249. J Immunol. 2008. PMID: 18490724

9

Can urinary exosomes act as treatment response markers in prostate cancer?

Mitchell PJ, Welton J, Staffurth J, Court J, Mason MD, Tabi Z, Clayton A. Mitchell PJ, et al. Among authors: clayton a. J Transl Med. 2009 Jan 12;7:4. doi: 10.1186/1479-5876-7-4. J Transl Med. 2009. PMID: 19138409 Free PMC article.

10

The rationale for combined chemo/immunotherapy using a Toll-like receptor 3 (TLR3) agonist and tumour-derived exosomes in advanced ovarian cancer.

Adams M, Navabi H, Croston D, Coleman S, Tabi Z, Clayton A, Jasani B, Mason MD. Adams M, et al. Among authors: clayton a. Vaccine. 2005 Mar 18;23(17-18):2374-8. doi: 10.1016/j.vaccine.2005.01.014. Vaccine. 2005. PMID: 15755631

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

736 results

Search Page

Filters